Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Pacira BioSciences Receives Paragraph IV Certification Notice Letter From Qilu Pharmaceutical; Qilu Has Filed Abbreviated New Drug Application For Product Claiming To Be Generic Equivalent Of EXPAREL, Pacira Says Intents To Assert Its IP Rights

Author: Benzinga Newsdesk | October 27, 2025 07:14am

Posted In: PCRX